Survival Following Implantable Cardioverter‐Defibrillator Implantation in Patients With Amyloid Cardiomyopathy
Higgins AY, Annapureddy AR, Wang Y, Minges KE, Lampert R, Rosenfeld LE, Jacoby DL, Curtis JP, Miller EJ, Freeman JV. Survival Following Implantable Cardioverter‐Defibrillator Implantation in Patients With Amyloid Cardiomyopathy. Journal Of The American Heart Association 2020, 9: e016038. PMID: 32867553, PMCID: PMC7726970, DOI: 10.1161/jaha.120.016038.Peer-Reviewed Original ResearchConceptsImplantable cardioverter defibrillator implantationCardioverter-defibrillator implantationNonischemic cardiomyopathyCardiac amyloidosisDiabetes mellitusCerebrovascular diseaseVentricular tachycardiaMultivariable Cox proportional hazards regression modelsCox proportional hazards regression modelProportional hazards regression modelsKaplan-Meier survival curvesCox proportional hazards modelPropensity-matched cohortOutcomes of patientsHazards regression modelsProportional hazards modelCause mortalityICD implantationRenal functionMultivariable analysisConclusions MortalityRisk factorsRegistry dataAmyloid cardiomyopathyHigh riskStent selection among patients with chronic kidney disease: Results from the NCDR CathPCI Registry
Feldman DA, Shroff AR, Bao H, Curtis JP, Minges KE, Ardati AK. Stent selection among patients with chronic kidney disease: Results from the NCDR CathPCI Registry. Catheterization And Cardiovascular Interventions 2020, 96: 1213-1221. PMID: 31909543, DOI: 10.1002/ccd.28698.Peer-Reviewed Original ResearchConceptsChronic kidney diseasePercutaneous coronary interventionST-elevation myocardial infarctionDES usageBare metal stentsNCDR CathPCI RegistryCathPCI RegistryRenal functionKidney diseasePCI casesElective percutaneous coronary interventionAdvanced renal dysfunctionNormal renal functionCoronary stent placementCKD stageRenal dysfunctionCoronary interventionUse of DESMyocardial infarctionStent placementSubgroup analysisStent usageMetal stentsPatientsStent selection